E. Franssen

2.3k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

E. Franssen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, E. Franssen has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in E. Franssen's work include BRCA gene mutations in cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). E. Franssen is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). E. Franssen collaborates with scholars based in Canada, United States and United Kingdom. E. Franssen's co-authors include Margaret I. Fitch, Geoffrey Liu, E Warner, Kenneth R. Chapman, LP Boulet, Ida Ackerman, Gillian Thomas, A.J. Dembo, J Balogh and Pamela Chart and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

E. Franssen

35 papers receiving 1.8k citations

Hit Papers

Patient preferences for oral versus intravenous palliativ... 1997 2026 2006 2016 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Franssen Canada 17 759 495 287 272 245 35 1.9k
Sherri L. Stewart United States 27 992 1.3× 410 0.8× 406 1.4× 168 0.6× 186 0.8× 79 2.3k
Åsa Klint Sweden 26 1.1k 1.5× 464 0.9× 360 1.3× 117 0.4× 111 0.5× 34 2.3k
H‐O Adami Sweden 25 658 0.9× 574 1.2× 414 1.4× 68 0.3× 244 1.0× 43 2.0k
Melanie Williams United States 18 850 1.1× 273 0.6× 289 1.0× 74 0.3× 211 0.9× 33 1.9k
Claire Falandry France 26 1.2k 1.6× 582 1.2× 477 1.7× 666 2.4× 150 0.6× 109 3.1k
Wakiko Ajiki Japan 29 1.2k 1.6× 877 1.8× 728 2.5× 80 0.3× 129 0.5× 66 2.7k
Bea C. Tanis Netherlands 23 326 0.4× 257 0.5× 280 1.0× 321 1.2× 78 0.3× 43 1.9k
Hassan Errihani Morocco 25 1.3k 1.8× 568 1.1× 514 1.8× 88 0.3× 91 0.4× 306 2.6k
Reda Wilson United States 20 985 1.3× 460 0.9× 258 0.9× 64 0.2× 113 0.5× 42 2.3k
Magdalena Bielska‐Lasota Poland 10 1.0k 1.4× 399 0.8× 330 1.1× 51 0.2× 97 0.4× 26 1.8k

Countries citing papers authored by E. Franssen

Since Specialization
Citations

This map shows the geographic impact of E. Franssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Franssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Franssen more than expected).

Fields of papers citing papers by E. Franssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Franssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Franssen. The network helps show where E. Franssen may publish in the future.

Co-authorship network of co-authors of E. Franssen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Franssen. A scholar is included among the top collaborators of E. Franssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Franssen. E. Franssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Kenneth R., et al.. (2007). Suboptimal asthma control: prevalence, detection and consequences in general practice. European Respiratory Journal. 31(2). 320–325. 273 indexed citations
2.
Sidhu, K., et al.. (2004). Delineation of brain metastases on CT images for planning radiosurgery: concerns regarding accuracy. British Journal of Radiology. 77(913). 39–42. 16 indexed citations
4.
Silverman, Jeffrey A., E. Franssen, Rena Buckstein, & Kevin Imrie. (2002). The Development of Marked Elevation in White Blood Cell Count Does Not Predict Inferior Outcome in Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 43(6). 1245–1251. 3 indexed citations
5.
Chow, Edward, L. Andersson, Rebecca Wong, et al.. (2001). Patients with Advanced Cancer: A Survey of the Understanding of Their Illness and Expectations from Palliative Radiotherapy for Symptomatic Metastases. Clinical Oncology. 13(3). 204–208. 63 indexed citations
6.
MacKenzie, Robert G., E. Franssen, Rebecca Wong, et al.. (2000). Risk-Adapted Therapy for Clinical Stage I–II Hodgkin's Disease: 7-Year Results of Radiotherapy Alone for Low-Risk Disease, and ABVD and Radiotherapy for High-Risk Disease. Clinical Oncology. 12(5). 278–288. 4 indexed citations
7.
Franssen, E., et al.. (1999). Gynecologists' perspectives regarding ovarian cancer.. PubMed. 3(1). 68–76. 4 indexed citations
8.
Chow, Edward, Cyril Danjoux, I Pataki, E. Franssen, & R. D. T. Jenkin. (1999). Effect of hemoglobin on radiotherapy response in children with medulloblastoma: Should patients with a low hemoglobin be transfused?. Medical and Pediatric Oncology. 32(5). 395–397. 7 indexed citations
9.
Fitch, Margaret I., Ross E. Gray, Denny DePetrillo, E. Franssen, & Doris Howell. (1999). Canadian women's perspectives on ovarian cancer.. PubMed. 3(1). 52–60. 26 indexed citations
10.
Warner, Ellen, Rajesh Kumar Goel, Warren Chow, et al.. (1998). A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS). British Journal of Cancer. 77(12). 2376–2380. 26 indexed citations
11.
Thomas, Gillian, A.J. Dembo, Ida Ackerman, et al.. (1998). A Randomized Trial of Standard versus Partially Hyperfractionated Radiation with or without Concurrent 5-Fluorouracil in Locally Advanced Cervical Cancer. Gynecologic Oncology. 69(2). 137–145. 87 indexed citations
12.
Liu, Geoffrey, E. Franssen, Margaret I. Fitch, & E Warner. (1997). Patient preferences for oral versus intravenous palliative chemotherapy.. Journal of Clinical Oncology. 15(1). 110–115. 786 indexed citations breakdown →
13.
Covens, Al, Gigi Thomas, Peter J. Shaw, et al.. (1997). A Phase II Study of Leuprolide in Advanced/Recurrent Endometrial Cancer. Gynecologic Oncology. 64(1). 126–129. 62 indexed citations
14.
Bendavid, Yves, et al.. (1995). Meta-analysis Comparing Cisplatin Total Dose Intensity and Survival. Gynecologic Oncology. 59(1). 93–101. 20 indexed citations
15.
Covens, Allan, Michael E. Carney, E. Franssen, et al.. (1995). Does Aggressive Therapy Improve Survival in Suboptimal Stage IIIc/IV Ovarian Cancer? A Canadian–American Comparative Study. Gynecologic Oncology. 59(2). 194–199. 15 indexed citations
16.
Jacobson, Michael C., E. Franssen, Dan M. Fliss, B. D. Birt, & Ralph Gilbert. (1995). Free Forearm Flap in Oral Reconstruction: Functional Outcome. Archives of Otolaryngology - Head and Neck Surgery. 121(9). 959–964. 65 indexed citations
18.
Salloum, Said A. & E. Franssen. (1993). Laboratory investigations in general practice.. PubMed. 39. 1055–61. 18 indexed citations
20.
Serby, Michael, et al.. (1988). Clinical stages of dementia and the dexamethasone suppression test. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 12(5). 833–836. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026